Revance Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
3/18/2025
Shares
92,880
Value ($000)
282
Weight
0.0%
2014 Q1 - 2024 Q4 (22 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).